Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Co-administration of the RSV and shingles adjuvanted vaccines was well tolerated, with acceptable reactogenicity and safety ...

Patrick Swanson, 62, of Blanchard has been fully vaccinated with the COVID vaccines, but he has opted out of the yearly flu ...

Responding to rising mpox cases in Africa, the World Health Organization declared a public health emergency of international ...

“QS-21 today is present in a blockbuster vaccine, probably the most important vaccine in the pre-COVID era, which is this shingles vaccine ... greater quantities, in reaction to that stress ...

However, as with many issues across modern society, there has been a degree of polarisation in people’s reactions to vaccination ... 10% of participants had a shingles vaccine, with 63% of ...

Anakinra is included on the PBS for arthritis, but Australia is yet to follow the US and Europe in subsidising the drug for pericarditis. While Abraham baulked at the cost, she knew she had to try it.

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...

The P.E.I. government has lowered the age requirement for a free shingles vaccine to 50. The change from age 60 was announced in a news release Monday morning and is effective immediately.

GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and older.